Baoji Pharmaceutical
Baoshan
About Baoji Pharmaceutical
Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $100.0M
- Funding stage: IPO
- Last round: Series C (Feb 2025)
- Ticker: hkg:2659
- Website: baopharma.com
- Phone: 021-56696602
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/baoji-pharmaceutical-90231 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.